can you see retatrutide on a drug test New Obesity Delivered Surgery-Level Weight Loss in Clinical Trials What you need to know

That determination is made during your consultation, not assumed in advance

Physicians should avoid prescribing it to: Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Individuals with severe gastrointestinal conditions, such as gastroparesis. Patients with a known allergy to GLP-1 receptor agonists. Pregnant or breastfeeding women, unless approved by a physician

Early studies showed that people on GLP-1s lost quite a bit of lean mass, which some took to mean the loss of muscle

GLP-1 has several salutary effects on the cardiovascular system, including anti-inflammatory effects, cardioprotection during ischaemia, natriuresis and diuresis, decreased platelet aggregation, and reduction in post-prandial lipid production [24]

PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols

doi: 10.1001/jama.2023.19897